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636a Wednesday, February 6, 2012Despite its long history of use and abuse in human culture, the molecular basis
for alcohol action in the brain is poorly understood. We recently characterized
alcohol modulation of GLIC, a prokaryotic pentameric ligand-gated ion chan-
nel, as a structurally acessible model system for important alcohol targets in
this family. Here, we validate GLIC as a model protein and explore possible
binding sites for allosteric modulators. Insertion of the transmembrane domain
of the human a1 glycine receptor into GLIC quantitatively determines alcohol
sensitivity of the chimeric protein, consistent with conservation of modular
domains and the presence of one or more transmembrane binding sites for
alcohol. Mapping of transmembrane residues that influence alcohol sensitivity
reveals their proximity to cavities whose volume correlate with alcohol cutoff.
Mutations in the intrasubunit cavity, which was recently shown to bind
inhibitory anesthetics, reveal selective effects on various inhibitors. Con-
versely, mutations in the intersubunit cavity demonstrate dramatic dependence
of potentiation by several modulators on cavity volume. Molecular dynamics
simulations up to 1 ms confirm enhanced ethanol occupancy in this intersubunit
cavity in an alcohol-sensitive variant of GLIC. Furthermore, docking of anes-
thetics allows us to calculate selectively-enhanced free energy of binding in the
intersubunit cavity of the alcohol-sensitive variant. Most recently, this work has
led to the determination of X-ray crystal structures of the alcohol-sensitive
mutant in the absence and presence of ethanol and other modulators (see
abstract by M. Delarue et al. in this conference), which we validate with addi-
tional functional mutants. These structures–the first atomic-resolution views of
any full-length ion channel bound to alcohol–confirm our functional and mod-
eling predictions of an intersubunit potentiating site, and provide new insights
into the complex molecular interactions underlying allosteric modulation of re-
ceptors in this family.
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Propofol is an intravenous general anesthetic that elicits many of its anesthetic
actions invivo by potentiating GABAAR responses. In addition to potentiating
inhibitory GABAARs, containing anion selective channels, propofol inhibits re-
lated cation-selective channels in the superfamily of pentameric ligand-gated
ion channels, including nicotinic acetylcholine receptors (nAChR) and GLIC,
a prokaryotic, proton-gated channel. A recent crystal structure of GLIC, pro-
duced by soaking GLIC crystals in propofol, identified an intrasubunit propofol
binding site in the pocket near the extracellular side of the membrane formed by
the bundle of four transmembrane helices (Nury et al., Nature 469:428 (2011)).
To identify propofol binding sites in GLIC in solution, we used a photoreactive
propofol analog, m-azipropofol (2-isopropyl-5-[3-(trifluoromethyl)-3H-
diazirin-3-yl]phenol) (Hall et al., J Med. Chem. 53:5667 (2010)). For GLIC
channels expressed in oocytes, m-azipropofol and propofol inhibit current re-
sponses at pH 5.5 (EC20) with IC50s of 5051 mM and 2051 mM, respectively.
[3H]m-Azipropofol (7 mM) was photoincorporated into detergent-solubilized,
affinity-purified GLIC at pH 4.4 in the absence and presence of 300 mM
propofol. [3H]m-Azipropofol photoincorporation into amino acids in each of
the GLIC transmembrane helices (M1-M4) was determined by protein
microsequencing of either Endoproteinase Lys-C or BNPS-skatol digests.
[3H]m-azipropofol photolabeled most efficiently two amino acids, Asn-307
in M4 and Tyr-254 in M3, and propofol inhibited photolabeling by >70%.
Thus, propofol and m-azipropofol bind competitively to a site in proximity to
Asn-307 and Tyr-254, side-chains that in the GLIC crystal structure are in con-
tact with the propofol molecule within the intrasubunit pocket formed by the
bundle of transmembrane helices. m-Azipropofol/propofol bind to an equiva-
lent site in the nAChR d subunit (SS Jayakar et al., Soc. Neuroscience Meeting
Planner 2011 #336.01/C2), whereas in the ab GABAAR they bind to a site at
the b-a interface (see Jayakar abstract).
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The Erwinia ligand-gated ion channel (ELIC) is a bacterial GABA-gated
cation-selective channel that shares structural homology with vertebrate Cys-
loop receptors[1]. Here we investigated the effects of Ca2þ on the functional
properties of ELIC using wild-type and mutant receptors. Receptors wereexpressed in Xenopus oocytes and characterised using two electrode voltage-
clamp electrophysiology. GABA concentration-response curves were recorded
in ND96 buffer with 0, 1.8, 5 or 10 mM Ca2þ. The data show that Ca2þ alters
the rate of apparent desensitization and the GABA EC50. To probe ion selec-
tivity the external NaCl concentration was altered and the effects on reversal
potential measured by clamping cells between 60 and þ100 mV in 10 mV
steps. These data showed that ELIC is predominantly cation selective as previ-
ously reported[2]. The 1’ (E229) residue has been identified as a critical re-
gion for controlling cation selectivity in Cys-loop receptors[3][4]. Consistent
with this, an E229A mutation in ELIC decreased cation selectivity. When
E229A was combined with a mutation at the N20’ position (E229A/N250R)
ELIC became predominantly anion selective, similar to experiments described
for the 5-HT3 receptor[4]. This mutant eliminated the effects of Ca2þ on ELIC,
demonstrating that Ca2þ effects are mediated either in the channel or in the
intracellular domain.
[1] Hilf & Dutzler., 2008, Nature, 452 (7185) 375-9.
[2] Zimmermann et al., 2011 PLoS Biol, 9 (6).
[3] Galzi et al., 1992 Nature, 359 (6395) 500-5.
[4] Thompson & Lummis, 2003 Br J Pharmacol, 140 359-65.
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Cys-loop receptors are pentameric ligand-gated ion channels that are responsi-
ble for fast excitatory and inhibitory transmission in the peripheral and central
nervous systems. Each receptor has an extracellular domain (ECD) that con-
tains the ligand-binding sites, a transmembrane domain (TMD) that forms
the ion channel pore and an intracellular domain (ICD). All prokaryotic homo-
logs of Cys-loop receptors, for example, GLIC and ELIC, lack an ICD that
consists of a 50 to 270 amino acid long loop in eukaryotes. Very little is
known about the structure of the ICD since none of the recently published
X-ray structures of prokaryotic homologs contained an ICD, and the Torpedo
nAChR cryo-EM structure resolved only 1/3rd of the ICD. We have recently
constructed chimeras in which the ICD from eukaryotic serotonin (5-HT3A)
receptors was inserted into GLIC (1).
To extend our studies we generated GLIC chimeras with ICDs from other Cys-
loop receptors (GlyR-a1, GABA-r1, nAChR-a7). All chimeras were expressed
heterologously in Xenopus laevis oocytes to investigate the ion channel func-
tionality by using two-electrode voltage clamp experiments. All functional
chimeras were also expressed in E. coli membranes to enable overexpression
and protein purification. Chimeric proteins were successfully purified by using
Ni-NTA affinity and size exclusion chromatography (SEC). Limited proteoly-
sis and spectroscopic methods (circular dichroism and fourier transform infra-
red spectroscopy) will be used to study conformational features and secondary
structure elements of eukaryotic ICDs of the engineered GLIC-ICD chimeras.
Our data will shed light on the structure and function of the intracellular domain
of Cys-loop receptors, which will enable identification of potentially important
drug targeting sites in intracellular domains for the treatment of neurodegener-
ative diseases.
1. Goyal R. et al, (2011). J Biol Chem 286, 34635-42
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ELIC and GLIC, two bacterial nicotinic receptor-like channels, are remarkably
amenable to both structural and functional studies. This observation, along with
the notion that the overall structure and functional properties of these channels
are very similar to those of their metazoan counterparts, amply justifies the use
of ELIC and GLIC as models for the entire superfamily. At the level of the
transmembrane pore, the structural model of ELIC shows a prominent constric-
tion around the 16’ position of the M2 alpha-helices, whereas that of GLIC
displays a much wider, semi-conical cavity with helices tilted away from the
long axis of the pore. As a result, the structural models of ELIC and GLIC
are often considered to represent the closed-channel and open-channel confor-
mations, respectively, of all members of the superfamily, a notion that assumes
that the end states of the gating conformational change are conserved across
orthologs. Thus far, attempts to capture the different physiologically relevant
conformations of each of these channels in well-diffracting crystals have failed.
Here, as an alternative approach to probe the transmembrane-pore domain in
the open-channel conformation, we studied the interaction of ELIC, GLIC
Wednesday, February 6, 2012 637aand the muscle nicotinic acetylcholine receptor (AChR) with pore blockers.
From the comparative analysis of these results, it appears as though the muscle
AChR and GLIC have very similar open-channel pore structures, whereas the
open-channel pore of ELIC seems much narrower, and thus, closer to the struc-
tural model of ELIC in its closed state. Hence, it is likely that the closed-to-
open conformational change of ELIC at the level of the pore domain is subtler
than the one that could be predicted if ELIC were to adopt a GLIC-like structure
in the open state.
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The outermost lipid-exposed M4 alpha-helix in the transmembrane domain of
each subunit of the nicotinic acetylcholine receptor (nAChR) plays an impor-
tant role in channel gating and may provide the allosteric link between
nAChR function and lipid sensitivity. The C-terminal residues of M4 appear
to be particularly important, with deletion mutations abrogating channel
activity. Post-M4 may influence channel gating via direct interactions with
the Cys-loop of the agonist binding domain, a structure that plays a key
role allosterically translating agonist binding into channel gating. In this com-
munication, we explore the role of post-M4 in the function of two prokary-
otic homologs, the pH-activated GLIC and the cystamine-activated ELIC.
using the two voltage electrode clamp apparatus, we show that single alanine
mutations of each of the five C-terminal residues in GLIC has little effect on
the pH50 for activation, with a slight loss of function only occurring upon
mutation of either of the phenylalanine residues F314 and F313 that extend
from post-M4 to interact with the remainder of the transmembrane domain.
Sequential deletions of post-M4 residues, however, have more dramatic
effects. Deletion of the three terminal residues (F316-F314) drops the pH50
from 4.74 down to 4.34. Further deletions lead to a complete loss of activity
showing that the extended length of post-M4 plays a critical role in GLIC
channel activity, as it does with the nAChR. Surprisingly, detrimental effects
of post M4 deletions were not observed with ELIC. In fact, deletion of post-
M4 residues in ELIC typically led to a slight gain in function, with EC50
values for cystamine decreasing from 0.81 mM (wild type) to ~0.50 mM.
Our results highlight distinct functional characteristics of two homologous
pLGICs.
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Background: A central tenet of ligand-receptor theory is that agonists bind
more tightly to active than to inactive receptors. This is a difficult concept to
test experimentally, because in most agonist-receptor systems, the act of as-
sessing agonist binding affinity results in receptor activation. In a1b2g2L
GABAA receptors, the anesthetic etomidate is an allosteric agonist at high
concentrations, and potentiates GABA activation at low concentrations. Sites
mediating both actions were photolabeled with azi-etomidate, identifying the
b2M286 sidechain as a contact point. We used a cysteine substitution and
sulfhydryl modification to study etomidate interactions with this sidechain.
Methods: using two-microelectrode voltage clamp electrophysiology in
Xenopus oocytes, we characterized etomidate agonism and potentiation of
GABA activation in a1b2M286Cg2L GABAA receptors. We studied cova-
lent modification of the b2M286C sidechain by a sulfhydryl-selective
reagent, para-chloromercuribenzenesulfonate (pCMBS) with and without
GABA. Etomidate-dependent protection of the sulfhydryl was also assessed.
Results: Oocyte-expressed a1b2M286Cg2L receptors displayed reduced
sensitivity to GABA, and no agonism by etomidate. However, etomidate
still enhanced GABA-activated currents from a1b2M286Cg2L receptors.
Exposure of a1b2M286Cg2L receptors to pCMBS irreversibly increased
activation by low (EC10) GABA. The apparent rate of pCMBS modifi-
cation increased with addition of GABA. Etomidate in a concentration-
dependent manner reduced the rate of b2M286C modification by pCMBS.
Etomidate protection at b2M286C was enhanced in the presence of
GABA. Conclusions: Etomidate, like azi-etomidate, binds next to the
b2M286 residue. Based on its apparent protectant potency, the affinity of
etomidate for GABA-bound receptors is greater than that for resting recep-
tors, as expected. Our results have important implications for both designing
and interpreting experiments that use mutations to map allosteric modulator/
agonist sites.
Support: NIH (R01GM89745 and P01GM58448)3272-Pos Board B427
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Propofol, a widely used intravenous general anesthetic, potentiates GABA-A
receptor (GABAAR) function at anesthetic concentrations, and ‘‘knock-in’’
mice expressing a single mutation at position 15 in the b3 subunit M2 helix
(bM2-15) have reduced sensitivity to many of the anesthetic effects of
propofol. However, the location of propofol’s binding site(s) remains to be
determined. Here we use a photoactive analog of propofol, [3H]m-azipropo-
fol(2-isopropyl-5-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenol), an aryl diazir-
ine with broad amino acid side chain reactivity, to identify propofol binding
site(s) in affinity-purified, expressed human a1b3 GABAARs in detergent/
asolectin solution. m-Azipropofol acts as a tadpole anesthetic with potency
(EC50 = 3mM) similar to propofol, and it acts as a low efficacy GABAAR
potentiator (Hall et al. 2010, J Med. Chem. 53, 5667). Irradiation of
GABAAR for 30 min at 365nm resulted in [
3H]m-azipropofol photoincorpora-
tion into both the a1 and b3 subunits that was inhibitable by propofol and
non-radioactive m-azipropofol with IC50s of 2853 mM and 6.751 mM,
respectively. Individual amino acids photolabeled by [3H]m-azipropofol
were identified by protein microsequencing of subunit fragments generated
by enzymatic or chemical digestion. In b3, there was propofol-inhibitable
photolabeling of b3Met-286, an amino acid that is photolabeled by [3H]azie-
tomidate in the etomidate binding site at the b3M3-a1M1 interface (Li et al.
2006, J Neurosci. 26, 11599, Chiara et al. 2012, Biochem. 51, 836). In a1,
[3H]m-azipropofol photolabeled a1Ile-239 within a1M1, located one helical
turn below a1Met-236 that is photolabeled by [3H]azietomidate. Consistent
with propofol and m-azipropofol binding to this etomidate site, they com-
pletely inhibit [3H]azietomidate photolabeling with IC50s of 4653 mM and
2353 mM, respectively. Both b3Met-286 and a1Met-236 are in close proxim-
ity to bM2-15, which docking calculations suggest may also be part of this
propofol binding site.
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Background: GABAA receptors are allosterically modulated by a variety of
compounds including etomidate and tetrahydrodeoxycorticosterone (THDOC).
Extrasynaptic abd GABAA receptors mediate tonic inhibition, and may be
more sensitive to modulators than synaptic abg receptors. Studies of concate-
nated subunit assemblies suggests that the subunit arrangement of abd may
vary (1). We compared the modulation by etomidate and THDOC on a1b3d
receptors with different subunit arrangements, and to a1b3g2L receptors.
Methods: Plasmids encoding concatenated GABAA receptor subunit
assemblies and free subunits were obtained from Prof. Erwin Sigel (Bern, Swit-
zerland). Xenopus oocytes were used to express b3-a1-d/b3-a1 and b3-a1-d/
a1-b3 receptors as well as free subunit mixtures. Effects of etomidate
(3 mM) or THDOC (1 mM) on maximal GABA-activated receptor currents
were measured using two-microelectrode voltage-clamp electrophysiology.
Etomidate enhancement of b3-a1-d/b3-a1 was assessed over a broad
[GABA] range, and analyzed with an allosteric model.
Results:High GABA elicited small currents in oocytes expressing b3-a1-d/b3-
a1 and b3-a1-d/a1-b3 receptors. THDOC produced similar large current
enhancements in b3-a1-d/b3-a1 and b3-a1-d/a1-b3 receptors. However,
etomidate produced a greater current enhancement in b3-a1-d/a1-b3 receptors
than in b3-a1-d/b3-a1. Etomidate increased the maximal response of b3-a1-d/
b3-a1 receptors to GABA and produced a small leftward shift in GABA EC50.
Discussion: using concatenated receptor constructs resulted in evidence of
d subunit incorporation that was not seen using free subunit mRNAs. GABA
is a weak partial agonist in a1b3d receptors, while etomidate and THDOC
modulate via different sites. Etomidate efficacy in a1b3d is similar to that in
a1b3g receptors with homologous subunit arrangement, and interactions at
b3/b3 interfaces may be more efficacious than those at b3/a1 interfaces.
Support: NIH (R01GM89745 and P01GM58448)
Reference:
1) Kaur KH et al, J. Biol Chem 2009;284:7889-96
